Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
University of Cincinnati Medical Center, Ohio 45267-0585, USA.
M R
MR
First
P
P
Weiskittel
M
M
Burton
M
M
Shah
D
D
Dreyer
P
P
Fleck
C
C
Bey
R
R
Peddi
D
D
Canafax
T J
TJ
Schroeder
D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004304:Dosage Forms; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine